Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.763
+0.123 (19.27%)
Nov 5, 2024, 3:48 PM EST - Market open
Athira Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -113.45 | -117.67 | -95.64 | -54.85 | -19.96 | -5.16 | |
Depreciation & Amortization | 0.97 | 0.97 | 0.85 | 0.48 | 0 | 0 | |
Other Amortization | - | - | - | - | - | 0.26 | |
Loss (Gain) From Sale of Investments | -1.11 | -1.41 | -0.42 | 0.49 | 0.25 | - | |
Stock-Based Compensation | 10.61 | 10.62 | 10.61 | 4.62 | 0.63 | 0.25 | |
Other Operating Activities | 0.23 | 0.21 | 0.2 | 0.16 | 1.4 | 0.26 | |
Change in Accounts Receivable | - | 1.23 | 1.11 | -1.04 | -1.3 | -0.02 | |
Change in Accounts Payable | 5.2 | 7.37 | 2.1 | 5.15 | 2.6 | 0.7 | |
Change in Unearned Revenue | - | - | - | - | -1.5 | - | |
Change in Other Net Operating Assets | -0.86 | -2.07 | 8.73 | 1.89 | -6.25 | - | |
Operating Cash Flow | -98.41 | -100.75 | -72.47 | -43.1 | -24.11 | -3.71 | |
Capital Expenditures | -0.06 | -0.3 | -1.14 | -1.57 | -2.32 | - | |
Investment in Securities | 66.75 | 95.39 | 58.81 | -2.51 | -207.78 | 1.5 | |
Other Investing Activities | - | - | - | - | 0.04 | 0.01 | |
Investing Cash Flow | 66.68 | 95.09 | 57.66 | -4.08 | -210.07 | 1.51 | |
Long-Term Debt Issued | - | - | - | - | 1.66 | 0.87 | |
Net Debt Issued (Repaid) | - | - | - | - | 1.66 | 0.87 | |
Issuance of Common Stock | 0.3 | 0.49 | 0.65 | 97.09 | 209.16 | 0.07 | |
Financing Cash Flow | 0.3 | 0.49 | 0.65 | 97.09 | 292.75 | 0.95 | |
Net Cash Flow | -31.43 | -5.17 | -14.15 | 49.91 | 58.57 | -1.26 | |
Free Cash Flow | -98.47 | -101.06 | -73.61 | -44.67 | -26.43 | -3.71 | |
Free Cash Flow Per Share | -2.58 | -2.66 | -1.95 | -1.21 | -2.21 | -1.04 | |
Levered Free Cash Flow | -68.05 | -60.9 | -36.5 | -31.15 | -18.95 | -2.43 | |
Unlevered Free Cash Flow | -68.05 | -60.9 | -36.5 | -31.15 | -18.72 | -2.47 | |
Change in Net Working Capital | 3.7 | -7.25 | -11.95 | -5.34 | 4.54 | -0.68 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.